TP53 and urinary bladder cancer: Not surprisingly, the study by Liu et al. [4], which was based on 9 bladder cancer cell lines, was only able to identify genomic biomarkers with sufficiently high incidence (and magnitude of effect), i.e., TP53 mutation, which is a common alteration in many cancers.